Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Lytix Biopharma AS

Closing information (x1000 EUR)

Closing information 2019/12 2018/12 (consolidated) 2017/12 (consolidated)
Turnover 679 More Arrow 1,180 More Arrow 4,040
Financial expenses 34 More Arrow 51 More Arrow 2,150
Earnings before taxes -3,287 Less Arrow -6,133 Less Arrow -7,056
Total assets 1,768 More Arrow 5,872 Less Arrow 4,786
Current assets 1,768 More Arrow 5,872 Less Arrow 4,785
Current liabilities 308 More Arrow 2,178 More Arrow 3,587
Equity capital 1,459 More Arrow 3,694 Less Arrow 1,198
- share capital 232 Less Arrow 224 Less Arrow 125
Employees (average) 8 11
Shareholders 0 0 0

Financial ratios

Fiscal year 2019/12 2018/12 (consolidated) 2017/12 (consolidated)
Solvency 82.5% Less Arrow 62.9% Less Arrow 25.0%
Turnover per employee 85 367
Profit as a percentage of turnover -484.1% Less Arrow -519.7% More Arrow -174.7%
Return on assets (ROA) -184.0% More Arrow -103.6% More Arrow -102.5%
Current ratio 574.0% Less Arrow 269.6% Less Arrow 133.4%
Return on equity (ROE) -225.3% More Arrow -166.0% Less Arrow -589.0%
Change turnover
Change turnover % -70% More Arrow 219%
Chg. No. of employees
Chg. No. of employees % 0%

Total value of public sale

Fiscal year 2019/12 2018/12 (consolidated) 2017/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.